As GLP-1 drugs become more prevalent, breweries can consider the following strategies: Product Diversification: Develop and promote a range of products, including lower-calorie beers and non-alcoholic beverages, to attract health-conscious consumers
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: A meta-analysis of randomised controlled trials
Phase 3 data showed 18.6% weight loss at 46 weeks
Serious events in observational data: A 2023 JAMA analysis comparing GLP-1RA users to non-users reported higher relative rates of certain GI events (biliary disease, pancreatitis, bowel obstruction, etc)
This step is crucial for ensuring that your liver, kidneys, and other detox organs are ready to handle the increased detoxification load
Total protein: roughly 80 grams